Neurostudies Inc.

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis4 trials
• Alzheimer disease2 trials
• Multiple system atrophy1 trial

Phase

• Phase 36 trials
• Phase 21 trial

Status

• Active, not recruiting6 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials
• Celgene1 trial
• Eisai Inc.1 trial
• IGC Pharma, LLC1 trial
• Theravance Biopharma1 trial

Running trials

• Active, not recruiting

  Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

  NCT06869785· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

  NCT05696717· Phase 3· Theravance Biopharma· Source

• Active, not recruiting

  Clinical Trial on Agitation in Alzheimer's Dementia

  NCT05543681· Phase 2· IGC Pharma, LLC· Source

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

  NCT05147220· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

  NCT03887455· Phase 3· Eisai Inc.· Source

• Active, not recruiting

  Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

  NCT03650114· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

  NCT05028634· Phase 3· Celgene· Source